A Multi-Stage Genome-Wide Association Study of Bladder Cancer Identifies Multiple Susceptibility Loci.
Nathaniel Rothman,Montserrat Garcia-Closas,Nilanjan Chatterjee,Nuria Malats,Xifeng Wu,Jonine D Figueroa,Francisco X Real,David Van Den Berg,Giuseppe Matullo,Dalsu Baris,Michael Thun,Lambertus A Kiemeney,Paolo Vineis,Immaculata De Vivo,Demetrius Albanes,Mark P Purdue,Thorunn Rafnar,Michelle A T Hildebrandt,Anne E Kiltie,Olivier Cussenot,Klaus Golka,Rajiv Kumar,Jack A Taylor,Jose I Mayordomo,Kevin B Jacobs,Manolis Kogevinas,Amy Hutchinson,Zhaoming Wang,Yi-Ping Fu,Ludmila Prokunina-Olsson,Laurie Burdett,Meredith Yeager,William Wheeler,Adonina Tardón,Consol Serra,Alfredo Carrato,Reina García-Closas,Josep Lloreta,Alison Johnson,Molly Schwenn,Margaret R Karagas,Alan Schned,Gerald Andriole Jr,Robert Grubb III,Amanda Black,Eric J Jacobs,W Ryan Diver,Susan M Gapstur,Stephanie J Weinstein,Jarmo Virtamo,Victoria K Cortessis,Manuela Gago-Dominguez,Malcolm C Pike,Mariana C Stern,Jian-Min Yuan,David J Hunter,Monica McGrath,Colin P Dinney,Bogdan Czerniak,Meng Chen,Hushan Yang,Sita H Vermeulen,Katja K Aben,J Alfred Witjes,Remco R Makkinje,Patrick Sulem,Soren Besenbacher,Kari Stefansson,Elio Riboli,Paul Brennan,Salvatore Panico,Carmen Navarro,Naomi E Allen,H Bas Bueno-de-Mesquita,Dimitrios Trichopoulos,Neil Caporaso,Maria Teresa Landi,Federico Canzian,Borje Ljungberg,Anne Tjonneland,Francoise Clavel-Chapelon,David T Bishop,Mark T W Teo,Margaret A Knowles,Simonetta Guarrera,Silvia Polidoro,Fulvio Ricceri,Carlotta Sacerdote,Alessandra Allione,Geraldine Cancel-Tassin,Silvia Selinski,Jan G Hengstler,Holger Dietrich,Tony Fletcher,Peter Rudnai,Eugen Gurzau,Kvetoslava Koppova,Sophia C E Bolick,Ashley Godfrey,Zongli Xu,José I Sanz-Velez,María D García-Prats,Manuel Sanchez,Gabriel Valdivia,Stefano Porru,Simone Benhamou,Robert N Hoover,Joseph F Fraumeni Jr,Debra T Silverman,Stephen J Chanock
DOI: https://doi.org/10.1038/ng.687
IF: 30.8
2010-01-01
Nature Genetics
Abstract:Montserrat Garcia-Closas and colleagues report a genome-wide association study for bladder cancer. They identify three new susceptibility loci on chromosomes 22q13.1, 19q12 and 2q37.1. We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which included 8,382 cases and 48,275 controls from 16 studies. In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10−12) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10−11) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10−7) maps to the UGT1A cluster on 2q37.1. We confirmed four previously identified genome-wide associations on chromosomes 3q28, 4p16.3, 8q24.21 and 8q24.3, validated previous candidate associations for the GSTM1 deletion (P = 4 × 10−11) and a tag SNP for NAT2 acetylation status (P = 4 × 10−11), and found interactions with smoking in both regions. Our findings on common variants associated with bladder cancer risk should provide new insights into the mechanisms of carcinogenesis.